reteplase
Selected indexed studies
- Reteplase versus Alteplase for Acute Ischemic Stroke. (N Engl J Med, 2024) [PMID:38884332]
- Reteplase: Structure, Function, and Production. (Adv Biomed Res, 2019) [PMID:31016177]
- Reteplase versus alteplase for acute ischemic stroke: Meta-analysis. (Am J Emerg Med, 2025) [PMID:40517710]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Reteplase versus Alteplase for Acute Ischemic Stroke. (2024) pubmed
- Reteplase: Structure, Function, and Production. (2019) pubmed
- Reteplase versus alteplase for acute ischemic stroke: Meta-analysis. (2025) pubmed
- Safety and Efficacy of Reteplase Versus Alteplase for Acute Ischemic Stroke: A Phase 2 Randomized Controlled Trial. (2024) pubmed
- Patency trials with reteplase (r-PA): what do they tell us? (1996) pubmed
- Reteplase. A review of its pharmacological properties and clinical efficacy in the management of acute myocardial infarction. (1996) pubmed
- Reteplase: a new thrombolytic for the treatment of acute myocardial infarction. (1999) pubmed
- Reteplase: a review of its use in the management of thrombotic occlusive disorders. (2006) pubmed
- Reteplase: A promising alternative in acute ischemic stroke management. (2024) pubmed
- Reteplase. (1999) pubmed